Ohse H
University of Tsukuba
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ohse H.
Journal of Cardiovascular Pharmacology | 1991
Yoshiyuki Uchida; M. Saotome; Nomura A; Hiroki Ninomiya; Ohse H; F. Hirata; Shizuo Hasegawa
Our accompanying paper demonstrated that endothelin-1 (ET-1 constricts guinea pig airways directly and indirectly through mediators such as histamine and arachidonate metabolites. In order to exclude the role of mast cells in bronchoconstriction, we sensitized guinea pigs and challenged them in vitro with an antigen (ovalbumin). In the postanaphylactic trachea, ET-1 caused a transient relaxation followed by constriction. Such relaxation by ET was also observed in the tracheas constricted with carbamylcholine. The relaxation was completely blocked by nordihydroguaretic acid and AA861, lipooxygenase inhibitors, but not by indomethacin, a cyclooxygenase inhibitor, and FPL 55712, a leukotriene antagonist. Because the relaxation was not affected even in the presence of methylarginine, an inhibitor of NO synthesis, and superoxide dismutase, an enzyme for destroying NO radical, we concluded that ET-1 induces the relaxation of the tracheal muscles by producing lipooxygenase products, probably hydroperoxides of arachidonic acid.
Journal of Cardiovascular Pharmacology | 1991
Nomura A; Hiroki Ninomiya; M. Saotome; Ohse H; Yukio Ishii; Yoshiyuki Uchida; F. Hirata; Shizuo Hasegawa
We investigated the mechanism of the endothelin-1 (ET-1)-induced bronchoconstriction of guinea pig tracheal smooth muscles. ET-1 contracted the tracheas in a dose-dependent manner. A combination of FPL55712 (leukotriene antagonist), diphenhydramine (histamine antagonist), and indomethacin (cyclooxygenase inhibitor) shifted the dose-response curve of ET-1 to the right and suppressed the maximal constriction. Azelastine, an antiallergic agent, exerted essentially similar results. The present data suggest that ET-1 constricts the airway smooth muscles not only by direct action on the tracheal smooth muscles but also by indirect action mediated through production of various chemical mediators in cells other than muscles.
Journal of Pharmacology and Experimental Therapeutics | 1996
Yoshiyuki Uchida; To Jun; Hiroki Ninomiya; Ohse H; Shizuo Hasegawa; Akihiro Nomura; Tohru Sakamoto; Maniklal Sardessai; Fusao Hirata
Pulmonary Pharmacology & Therapeutics | 1997
Takeo Endo; Yoshiyuki Uchida; Akihiro Nomura; Hiroki Ninomiya; Ohse H; M. Saotome; Y Noguchi; Shizuo Hasegawa
The journal of the Japanese Respiratory Society | 1998
Takeo Endo; Takefumi Saito; Mika Nakayama; Ohse H; Watanabe S; Tamai S; Shizuo Hasegawa
The journal of the Japanese Respiratory Society | 1999
Takeo Endo; Takefumi Saito; Mika Nakayama; Ohse H; Watanabe S; Tamai S; Shizuo Hasegawa
Kekkaku(Tuberculosis) | 1997
Ohse H; Takefumi Saito; Kennosuke Kadono; Kuniyoshi Hirano; Watanabe S; Noboru Yanai; Etsuo Nemoto; Shimao Fukai; Yukio Ishii; Shizuo Hasegawa
Kekkaku(Tuberculosis) | 1995
Ohse H; Yukio Ishii; Takefumi Saito; Watanabe S; Shimao Fukai; Noboru Yanai; Tamai N; Monma Y; Shizuo Hasegawa
Arerugī (Allergy) | 1991
M. Saotome; Hiroki Ninomiya; Nomura A; Ohse H; Endoh T; Shizuo Hasegawa; Yoshiyuki Uchida
The journal of the Japanese Respiratory Society | 2000
Takeo Endo; Takefumi Saito; Ohse H; Mika Nakayama; Watanabe S; Kiyohisa Sekizawa; Shizuo Hasegawa